This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Telix Pharmaceuticals has entered an agreement to add Subtle Medical’s AI software for enhancing prostate-specific membrane antigen (PSMA) PET prostate cancer scans to its product portfolio. SubtlePET is a U.S. Food and Drug Administration (FDA) cleared deep-learning algorithm designed to enhance the efficiency and effectiveness of imaging procedures, Telix said.
Greg Murphy, MD, R-N.C., and colleagues are proposing the Medicare Patient Access and Practice Stabilization Act, which would halt a 2.8% reduction to the conversion factor.
MRI shows that increases in the brain's white matter and ventricle volume are risk factors for the progression of mild cognitive impairment (MCI), according to a study published October 30 in JAMA Network Open. A team led by Yuto Uchida, MD, PhD, of Johns Hopkins University School of Medicine in Baltimore found that higher volumes in these brain characteristics -- along with the presence of type 2 diabetes and abnormal beta-amyloid ratios in the cerebrospinal fluid (CSF) -- were associated with
Amidst rising cancer prevalence and soaring costs, new cancer technologies and innovations are emerging to support the early detection, treatment, and surveillance of cancer. Read this guide to understand how to evaluate these solutions for your employees and members – and to learn more about the current state of coverage, clinical and cost effectiveness, and impact on quality and outcomes.
Konica Minolta Healthcare is introducing Exa Enterprise, a new enterprise imaging solution that encompasses the Exa PACS-RIS core powered by AWS’s proven cloud solution and its data. This new enterprise cloud solution will deliver exceptionally fast access to data and boost efficiency across imaging specialties.
The announcement will come as welcome news, as nuclear medicine departments in numerous regions have been grappling with shortages of Mo-99 and Tc-99m.
The announcement will come as welcome news, as nuclear medicine departments in numerous regions have been grappling with shortages of Mo-99 and Tc-99m.
With deep sadness, the ESR announces the passing of Prof. Willi Kalender on October 20, 2024 at the age of 75. A pioneering figure in diagnostic imaging and medical physics, Prof. Kalender significantly influenced the field through his groundbreaking research and leadership. Dedicating his career to advancing diagnostic radiology, particularly in CT imaging technology, Prof.
Multidisciplinary collaboration may be key to successfully integrating radiology education into clinical clerkships, according to research published October 29 in Clinical Imaging. A team led by Lily Belfi, MD, from Weill Cornell Medicine in New York, found in a pilot study that its radiologist-led standardized interactive teaching sessions improved students’ knowledge of radiology concepts and understanding of radiology’s role in clinical care.
Patient-centric scheduling can only be achieved through optimized radiology workflows, effective communications between staff and physicians, and, of course, through specialized schedulers. In this guide, we’ll take you through a step-by-step process to transform your radiology center into a high-performance hub of medical imaging.
Elon Musk is inviting submission of medical images to xAI's Grok. He issued the invitation on October 29 on X.com (formerly Twitter), writing "Try submitting x-ray, PET, MRI or other medical images to Grok for analysis. This is still early stage, but it is already quite accurate and will become extremely good. Let us know where Grok gets it right or needs work.
MRI has an important role in assessing Ductal Carcinoma in Situ risk and guiding treatment decisions for women who elect not to undergo standard surgical management and instead opt for endocrine treatment and imaging surveillance.
Bracco Imaging subsidiary Blue Earth Therapeutics has closed on $76.5 million in a series A financing round. The funds will support phase II studies of the company’s experimental theranostic radiopharmaceuticals for imaging and treating prostate cancer, the company said. Blue Earth has developed a radiohybrid (rh) prostate-specific membrane antigen (rhPSMA-10.1) ligand that targets PSMA receptors on cancer cells.
About 40% of us will be diagnosed with cancer in our lifetime, and patients are getting younger. At the same time, the cost of treatment continues to rise, with employers spending 8.5% more on cancer care for each employee than they did last year. The best thing employers can do for their employees and business tomorrow is to invest in cancer detection and care today.
GE HealthCare (GEHC) reported a 1% growth in existing operation revenues and an increase in profitability in its second quarter of 2024, citing solid performance in its Pharmaceutical Diagnostics segment. For the period (end-September 30), GEHC had total revenues of $4.86 billion, flat compared with $4.82 billion in the same period last year. However, existing operation revenues reached $4.863 billion, up 1% from $4.822 billion in the third quarter of last year.
For clinically actionable pneumothorax, an artificial intelligence algorithm demonstrated a 93 percent AUC and a 96 percent specificity rate in a study involving chest X-rays from over 27,000 adults.
Normal supplies of molybdenum-99 are expected to be available by the beginning of the week of November 11, according to the Society of Nuclear Medicine and Molecular Imaging (SNMMI). On October 14, Nuclear Medicine Europe (NMEU) announced that a delayed restart of the High Flux Reactor (HFR) in the Netherlands was expected to cause supply shortages of Mo-99 to technetium-99 m (Tc-99m) generator manufacturers into November.
Emerging technologies included with the 10th version of the 1.5T MRI platform include Synergy DLR Clear and Synergy Vision that are geared toward mitigating common challenges with artifacts.
Discover how Color's comprehensive care solution is revolutionizing cancer screening adherence and knowledge. Through an in-depth case study, Color's unique approach to comprehensive cancer care has shown significant benefits in increasing screening rates and enhancing patient knowledge. Participants reported a 2-3x increase in adherence to screening guidelines over just 8 weeks, with 84% of participants increasing their familiarity with timing and frequency of cancer screening.
Merit Medical posted 7.8% increase in revenue in the third quarter of 2024 compared with Q3 2023. For the period (end-September 30), the company reported revenue of $339.8 million compared with $315.2 million in 2023. Net income was $28.4 million compared with $25.8 million last year. The company reported growth in its cardiovascular segment of 5.5%, from $306 million in 2023 to $322.8 million this year.
UCSF Radiology and Biomedical Imaging scientists and doctors are improving how we diagnose, monitor, and treat breast cancer with AI, advanced imaging, and enhancements to the patient experience.
tim.hodson Wed, 10/30/2024 - 10:25 Oct. 29, 2024 — NewVue and Enlitic recently announced a bi-directional strategic partnership that will leverage the proprietary AI algorithms of both companies to automate data standardization in radiology, solving a long-standing challenge faced by healthcare organization, eliminating the need for manual data normalization and transforming key areas such as PACS viewer hanging protocols, dictation system template selection, worklist case assignment and AI stud
Explore the latest insights from the American Cancer Society's “Cancer Statistics 2024” report, which unveils multiple alarming trends in cancer data. Cancer is on the rise among young adults, and diagnoses for 6 of the 10 most common cancers are escalating. With over 2 million new cancer cases projected in the U.S. this year, employers face increased challenges when it comes to supporting employees.
Ultrasound technology, once primarily used for imaging, is rapidly evolving into a targeted therapy that could significantly affect brain health, as highlighted in a recent article.
The theme at HLTH 2024 was clear: disruption, but this time it’s coming from within health systems, not just from big tech and consumer brands. From new business models to AI implementation and skills-focused recruitment, here are four insights and major announcements that got people talking. Disruption is Coming from Within Health Systems Greg Adams, Chair and CEO at Kaiser Permanente, outlined the strategy behind Risant Health, a venture launched in 2023 to challenge traditional healthcare mod
An AI method for measuring prostate tumor volume based on multiparametric MRI (mpMRI) data shows promise for predicting treatment outcomes, researchers have reported. "[We found that the] volume of AI-segmented intraprostatic tumors was an independent prognostic factor for outcomes of localized prostate cancer treated with radical prostatectomy and radiation therapy," wrote a group led by David Yang, MD, of Brigham and Women's Hospital in Boston.
Take Home Points Early diagnosis: erythema and warmth of the skin surrounding the umbilicus isn’t normal. Get labs, start abx and get the patient admitted Consult peds surgery on all of these patients as progression to nec fast, while uncommon, is devastating If the patient appears toxic or has systemic symptoms, the simply omphalitis has progressed and aggressive treatment including surgery is likely indicated REBEL Core Cast 130.0 – Omphalitis Click here for Direct Download of the Podcas
As HR and Benefits leaders are in the midst of evaluating cancer care solutions and designing their requirements for vendors, it’s key to know what questions to ask to ensure the development of a truly comprehensive strategy: from prevention to diagnosis to treatment to survivorship. Getting to the right answers starts with asking the right questions: How can better access improve engagement?
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content